Egetis Therapeutics

Major Shareholding Notification • Nov 7, 2020

Issuer Egetis Therapeutics AB (publ)

Holder

Fjärde AP-fonden

Instrument

Instrument	Aktie
Before the transaction
Shares	3,238,427
Voting rights	3,238,427
Transaction
Reason for major shareholding notification Other
Date	05/11/2020
Limit for number of shares	5 %
Limit for number of votes	5 %
After the transaction
Quantity
Shares	3,238,427
Directly held voting rights	3,238,427
Indirectly held voting rights	0
Percentage
Directly held shares	2.76 %
Directly held voting rights	2.76 %
Indirectly held voting rights	0 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	2.76 %	3,238,427
Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled - Cash settled
Total	2.76 %	3,238,427
Group total holdings
Voting rights 3,238,427 Percentage of voting rights 2.76
Published 07/11/2020 14:19
Contact
Name Jannis Kitsakis
Phone 070-6038023 Email jannis.kitsakis@ap4.se
CLOSE PRINT

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25